US-based healthcare diagnostic company Alzeca Biosciences Inc has secured $11m through a series A venture financing round.
The company plans to use the funds towards the development of its ADx nanoparticle.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
UK-based point-of-care company Sphere Medical Holding Plc plans to raise a total of £8m ($9.84m) through two private placements of 283 million convertible preferred shares priced at £0.03 ($0.04) each.
Senseonics Holdings Inc has announced a public offering of 11 million common stock shares priced at $2.15 each to raise $25.02m.
The US-based company plans to use the funds towards the commercialisation of its glucose monitoring system named Eversense and for general corporate purposes.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
